Format

Send to

Choose Destination
See comment in PubMed Commons below
Pathol Biol (Paris). 2013 Oct;61(5):184-92. doi: 10.1016/j.patbio.2012.04.003. Epub 2012 May 29.

[Homocysteine, vitamin B-12, folic acid and the cognitive decline in the elderly].

[Article in French]

Author information

  • 1Department of Biochemistry, Faculty of Medicine of Sousse, 4002 Sousse, Tunisie. Electronic address: dalifms@yahoo.fr.

Abstract

Hyperhomocysteinemia is a risk factor for neurological diseases, but the underlying pathophysiology has not been adequately explained. Mild hyperhomocysteinemia, which is sometimes associated with a low plasma level of vitamin B9, B12 and folic acid, is responsible in the toxicity in neural cell by activating NMDA receptor. Indeed, even if vitamin supplementation has clearly proven its efficiency on lowering plasma levels of homocysteine, recent studies do not show any positive effect of vitamin therapy on cognitive function. The hypothesis that this therapy is inefficient has been recently reinforced by two randomized trials on the effects of vitamin supplementation. Several hypotheses still need to be explored: Mechanisms of homocysteine toxicity and that of total uselessness of vitamin supplementation; the possible need to complete the actual data with further, more powerful studies in order to prove the role of homocysteine in the development of neurodegenerative diseases and a clinical effect of vitamin therapy.

KEYWORDS:

Dementia; Démence; Homocysteine; Homocystéine; Hyperhomocysteinemia; Hyperhomocystéinémie; Supplémentation vitaminique; Vitamin supplementation

PMID:
22647793
DOI:
10.1016/j.patbio.2012.04.003
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center